119 related articles for article (PubMed ID: 11882582)
1. Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth.
Dubey RK; Gillespie DG; Zacharia LC; Rosselli M; Imthurn B; Jackson EK
Hypertension; 2002 Feb; 39(2 Pt 2):412-7. PubMed ID: 11882582
[TBL] [Abstract][Full Text] [Related]
2. Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells.
Dubey RK; Gillespie DG; Keller PJ; Imthurn B; Zacharia LC; Jackson EK
Hypertension; 2002 Feb; 39(2 Pt 2):418-24. PubMed ID: 11882583
[TBL] [Abstract][Full Text] [Related]
3. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs.
Barchiesi F; Jackson EK; Gillespie DG; Zacharia LC; Fingerle J; Dubey RK
Hypertension; 2002 Apr; 39(4):874-9. PubMed ID: 11967242
[TBL] [Abstract][Full Text] [Related]
4. Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast.
Dubey RK; Jackson EK; Gillespie DG; Rosselli M; Barchiesi F; Krust A; Keller H; Zacharia LC; Imthurn B
J Clin Endocrinol Metab; 2005 Jan; 90(1):247-55. PubMed ID: 15507517
[TBL] [Abstract][Full Text] [Related]
5. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs.
Dubey RK; Gillespie DG; Zacharia LC; Barchiesi F; Imthurn B; Jackson EK
Hypertension; 2003 Mar; 41(3 Pt 2):807-13. PubMed ID: 12624000
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines block the antimitogenic effect of estradiol on human glomerular mesangial cells.
Dubey RK; Zacharia LC; Gillespie DG; Imthurn B; Jackson EK
Hypertension; 2003 Sep; 42(3):349-55. PubMed ID: 12913061
[TBL] [Abstract][Full Text] [Related]
7. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice.
Zacharia LC; Gogos JA; Karayiorgou M; Jackson EK; Gillespie DG; Barchiesi F; Dubey RK
Circulation; 2003 Dec; 108(24):2974-8. PubMed ID: 14662705
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells.
Zacharia LC; Jackson EK; Gillespie DG; Dubey RK
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1745-50. PubMed ID: 11701460
[TBL] [Abstract][Full Text] [Related]
9. Catecholamines block 2-hydroxyestradiol-induced antimitogenesis in mesangial cells.
Zacharia LC; Jackson EK; Gillespie DG; Dubey RK
Hypertension; 2002 Apr; 39(4):854-9. PubMed ID: 11967239
[TBL] [Abstract][Full Text] [Related]
10. Catecholamines block the antimitogenic effect of estradiol on human coronary artery smooth muscle cells.
Dubey RK; Jackson EK; Gillespie DG; Zacharia LC; Imthurn B
J Clin Endocrinol Metab; 2004 Aug; 89(8):3922-31. PubMed ID: 15292328
[TBL] [Abstract][Full Text] [Related]
11. Catechol-o-methyltransferase and methoxyestradiols participate in the intraoviductal nongenomic pathway through which estradiol accelerates egg transport in cycling rats.
Parada-Bustamante A; Orihuela PA; Ríos M; Navarrete-Gómez PA; Cuevas CA; Velasquez LA; Villalón MJ; Croxatto HB
Biol Reprod; 2007 Dec; 77(6):934-41. PubMed ID: 17699737
[TBL] [Abstract][Full Text] [Related]
12. 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth.
Dubey RK; Gillespie DG; Jackson EK; Keller PJ
Hypertension; 1998 Jan; 31(1 Pt 2):522-8. PubMed ID: 9453356
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
[TBL] [Abstract][Full Text] [Related]
14. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms.
Dubey RK; Gillespie DG; Zacharia LC; Rosselli M; Korzekwa KR; Fingerle J; Jackson EK
Biochem Biophys Res Commun; 2000 Nov; 278(1):27-33. PubMed ID: 11071850
[TBL] [Abstract][Full Text] [Related]
15. Medroxyprogesterone abrogates the inhibitory effects of estradiol on vascular smooth muscle cells by preventing estradiol metabolism.
Dubey RK; Jackson EK; Gillespie DG; Zacharia LC; Wunder D; Imthurn B; Rosselli M
Hypertension; 2008 Apr; 51(4):1197-202. PubMed ID: 18259021
[TBL] [Abstract][Full Text] [Related]
16. Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells.
Zacharia LC; Jackson EK; Gillespie DG; Dubey RK
Hypertension; 2001 Feb; 37(2 Pt 2):658-62. PubMed ID: 11230352
[TBL] [Abstract][Full Text] [Related]
17. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth.
Xiao S; Gillespie DG; Baylis C; Jackson EK; Dubey RK
Hypertension; 2001 Feb; 37(2 Pt 2):645-50. PubMed ID: 11230350
[TBL] [Abstract][Full Text] [Related]
18. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors.
Dubey RK; Gillespie DG; Mi Z; Jackson EK
Circulation; 1997 Oct; 96(8):2656-66. PubMed ID: 9355907
[TBL] [Abstract][Full Text] [Related]
19. A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts.
Dubey RK; Gillespie DG; Zacharia LC; Mi Z; Jackson EK
Hypertension; 2001 Feb; 37(2 Pt 2):716-21. PubMed ID: 11230362
[TBL] [Abstract][Full Text] [Related]
20. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism.
Dubey RK; Jackson EK; Keller PJ; Imthurn B; Rosselli M
Hypertension; 2001 Feb; 37(2 Pt 2):640-4. PubMed ID: 11230349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
